← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2011Last known activity
Aug 31, 2024
Timeline
1990s
- Jun 1, 1995
Savara Inc.— Founded
2010s
- Apr 27, 2017
Mast Therapeutics— Acquired
Drugs by trial phase (15 distinct, 34 trials)
Phase 3 (2 own, 7 via acquisition)
Phase 2 (1 own, 2 via acquisition)
Phase 1 (0 own, 3 via acquisition)
Indications
Subsidiaries (1 direct, 2 total across the full acquisition tree)
Recent trials (13)
- NCT06546098Lead sponsorN/A—
- NCT06431776Lead sponsorPhase 3Aug 31, 2024
- NCT06431776OfficialPhase 3Aug 31, 2024
- NCT04544293Lead sponsorPhase 3Feb 28, 2021
- NCT03597347Lead sponsorPhase 2Mar 15, 2019
- NCT03482752Lead sponsorPhase 3Apr 16, 2018
- NCT03421743Lead sponsorPhase 2Mar 1, 2018
- NCT03181932Lead sponsorPhase 3Sep 15, 2017
- NCT02702180Lead sponsorPhase 2/Phase 3Feb 1, 2016
- NCT02595060Lead sponsorPhase 2Jan 1, 2016
- NCT02468908Lead sponsorPhase 1May 1, 2015
- NCT01746095Lead sponsorPhase 2Mar 1, 2013
- NCT01537666Lead sponsorPhase 1Nov 1, 2011
Details
- Founded
- West Lake Hills, TX, US Jun 1, 1995
- Last known activity
- Aug 31, 2024